Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001347 · ClinicalTrials.gov registry record
Study of Usher Syndromes, Type 1 and Type 2
A clinical trial, sponsored by National Eye Institute (NEI).
- Completed
- Registry status
- 200
- Enrollment target
NCT00001347 is a clinical trial that has completed, run by National Eye Institute (NEI). The registered enrollment target is 200 participants.
The verdict
NCT00001347 has completed, sponsored by National Eye Institute (NEI).
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
The purpose of this investigation is to gain additional knowledge about what causes type 1 and type 2 Usher syndrome-inherited diseases that can cause balance problems and impaired hearing and vision-and to develop better diagnostic tests. Patients with type 1 Usher syndrome usually are deaf from birth and have speech and balance problems. Patients with type 2 disease generally are hearing impaired but have no balance problems. All patients develop eye problems that cause difficulty seeing in the dark. The development of newer and more sophisticated diagnostic tests may detect subtle differences in signs and symptoms that allow more accurate distinction between the two types of Usher syndrome. This study will use these tests to classify these syndromes and eventually identify the genes responsible for them. Study participants will have a medical and family history taken and a family tree constructed. They will undergo a thorough eye examination, including special tests of color vision, field of vision, and ability to see in the dark. An electroretinogram will be done to measure the function of cells in the retina, and a procedure called fluorescein angiography will be done to look at and photograph the blood vessels in the retina. Special hearing and balance tests will also done. Hearing tests include physical examination of the ears and wearing earphones while listening to tones. Balance and coordination tests require tasks such as walking in a straight line and standing in the dark with eyes closed. A caloric stimulation test will also be done, in which a small amount of water is irrigated into the ear canal. For gene studies, blood samples will be collected from patients and all available family members.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 1993-06 |
| Est. Completion | 2002-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001347
The ClinicalTrials.gov registry entry for NCT00001347 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Eye Institute (NEI), which has 221 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00001347 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00001347 about?
NCT00001347 is a clinical study titled "Study of Usher Syndromes, Type 1 and Type 2". The purpose of this investigation is to gain additional knowledge about what causes type 1 and type 2 Usher syndrome-inherited diseases that can cause balance problems and impaired hearing and vision-and to develop better diagnostic tests. Patients with type 1 Usher syndrome usually are deaf from bi...
What is the current status of trial NCT00001347?
This trial is currently completed. The enrollment target is 200 participants. The study started on 1993-06. Estimated completion is 2002-08.
Who is sponsoring clinical trial NCT00001347?
This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.